Asia Pacific Companion Animal Diagnostics Market

The Asia Pacific companion animal diagnostics market was valued at US$ 784.93 million in 2022 and is expected to reach US$ 1,640.70 million by 2030; it is estimated to register a CAGR of 9.7% from 2022 to 2030.

Upsurge in Pet Spending Fuels Asia Pacific Companion Animal Diagnostics Market

A large number of pet owners spend significantly on animal healthcare, particularly on veterinary care, diagnostics, and pharmaceuticals. Pet wellness and preventive diagnostic testing is still in its early stages. Animals can suffer from chronic illnesses such as arthritis, cancer, and allergies, similar to humans. Chronic diseases in pets have become more prevalent, which has a significant impact on people's spending on their pets' well-being and health. As per the Animal Medicines Australia data, across the country, the six most common pet types account for around ~US$ 22 billion in annual spending on pet-related goods and services. Food continues to be the largest category, accounting for 51% of total spending. Veterinary services come in second at 14%. Veterinary services accounted for ~US$ 3.11 billion in 2022. Thus, the growing prevalence of chronic diseases has become a more significant factor in the increase in pet spending. For instance, according to HealthforAnimals globally, an estimated US$ 4.6 billion was spent on companion animal diagnostics in 2022.

Asia Pacific Companion Animal Diagnostics Market Overview

The Asia Pacific companion animal diagnostics market has been segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in this region is expected to grow at the fastest CAGR among all other regions during 2022-2030. The companion animal diagnostics market growth in Asia Pacific is attributed to the rising focus on animal welfare and the burgeoning number of diagnostic laboratories in countries such as Japan, South Korea, and Australia. The gradually developing pet care industry in India and the ongoing implementation of international standards in China are expected to contribute to the market progress in this region during 2023-2030.

The initiatives of the Chinese government to stop the dog and cat meat consumption, followed by Zhuhai such needed action helped the government to deal with the challenges posed by animal disease burden through disease reporting system establishment, laws and regulations, special projects implementation for primary infectious diseases, foreign disease surveillance, and health education. In March 2016, the Chinese Government released national standards governing how laboratory animals are treated. The aim of setting these standards was to encourage ethically appropriate handling of animals and improve China's prospects for international research collaborations. Thus, government support to enhance animal health is likely to favor the growth of the companion animal diagnostics market.

Asia Pacific Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Companion Animal Diagnostics Market Segmentation

The Asia Pacific companion animal diagnostics market is segmented based on technique, product, application, companion animal type, end user, and country.

Based on technique, the Asia Pacific companion animal diagnostics market is segmented into immunodiagnostics, clinical biochemistry, molecular diagnostics, urinalysis, hematology, and others. The immunodiagnostics segment held the largest share in 2022. Immunodiagnostics segment is further categorized into lateral assays, ELISA tests, allergen-specific immunodiagnostics tests, and immunoassay analyzers. Clinical biochemistry segment is further categorized into clinical chemistry analysis, glucose monitoring, and blood gas electrolyte analysis. Also, biochemistry segment is categorized into PCR, microarray, and others.

By product, the Asia Pacific companion animal diagnostics market is bifurcated into instruments and consumables. The instruments segment held a larger share in 2022.

Based on application, the Asia Pacific companion animal diagnostics market is categorized into bacteriology, clinical pathology, virology, parasitology, and others. The clinical pathology segment held the largest share in 2022.

In terms of companion animal type, the Asia Pacific companion animal diagnostics market is segmented into dogs, cats, horses, and others. The dogs segment held the largest share in 2022.

Based on end user, the Asia Pacific companion animal diagnostics market is segmented into diagnostic laboratories, veterinary hospitals and clinics, research institutes, and others. The veterinary hospitals and clinics segment held the largest share in 2022.

By country, the Asia Pacific companion animal diagnostics market is categorized into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific companion animal diagnostics market in 2022.

ARI Medical Technology Co Ltd, Tianjin LOCMEDT Technologies Co Ltd, Heska Corp, i-SENS Inc, Universal Biosensors Inc, Immunology Consultants Laboratory Inc, Zoetis Inc, and Elabscience Biotechnology Inc are some of the leading companies operating in the Asia Pacific companion animal diagnostics market.